Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Antitubercular Agents. --- Antitubercular Drugs --- Tuberculostatic Agents --- Agents, Antitubercular --- Agents, Tuberculostatic --- Drugs, Antitubercular --- Mycobacterium tuberculosis --- Tuberculosis --- Antitubercular agents --- Antitubercular agents. --- Antituberculose middelen. (Versch. onderwerpen) --- Tuberculose. Chimiothérapie. (Mélanges) --- Antituberculeux (Agents). (Mélanges) --- Tuberculose. Chemotherapie. (Versch. onderwerpen) --- Anti-Tuberculosis Agent --- Anti-Tuberculosis Agents --- Anti-Tuberculosis Drug --- Anti-Tuberculosis Drugs --- Antitubercular Agent --- Antitubercular Drug --- Tuberculostatic Agent --- Agent, Anti-Tuberculosis --- Agent, Antitubercular --- Agent, Tuberculostatic --- Anti Tuberculosis Agent --- Anti Tuberculosis Agents --- Anti Tuberculosis Drug --- Anti Tuberculosis Drugs --- Drug, Anti-Tuberculosis --- Drug, Antitubercular --- Antitubercular Agents

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Multidrug-resistant tuberculosis (MDR-TB) has been recorded at the highest rates ever, according to this new report that presents findings from the largest survey to date on the scale of drug resistance in tuberculosis.This fourth global report is based on information collected between 2002 and 2006 on 90,000 TB patients in 81countries. It also found that extensively drug-resistant tuberculosis (XDR-TB), a virtually untreatable form of therespiratory disease, has been recorded in 45 countries. The primary aim of this report is to share survey and surveillance data on drug resistance in TB. The

Drug resistance -- Statistics. --- Drug Resistance, Bacterial -- statistics. --- Multidrug-resistant tuberculosis -- Statistics. --- Tuberculosis -- Prevention -- Statistics. --- Tuberculosis, Multidrug-Resistant -- epidemiology. --- Tuberculosis. --- WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. --- Tuberculosis --- Multidrug-resistant tuberculosis --- Drug resistance --- Respiratory Tract Infections --- Drug Resistance, Microbial --- Publication Formats --- Information Science --- Epidemiologic Methods --- Bacterial Physiological Phenomena --- Lung Diseases --- Public Health --- Health Care Evaluation Mechanisms --- Data Collection --- Statistics --- Drug Resistance, Bacterial --- Tuberculosis, Pulmonary --- Epidemiology --- Tuberculosis, Multidrug-Resistant --- Drug Resistance --- Respiratory Tract Diseases --- Investigative Techniques --- Medicine --- Quality of Health Care --- Mycobacterium Infections --- Microbiological Phenomena --- Publication Characteristics --- Actinomycetales Infections --- Phenomena and Processes --- Health Occupations --- Diseases --- Environment and Public Health --- Pharmacological Phenomena --- Health Care Quality, Access, and Evaluation --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Health Care --- Disciplines and Occupations --- Gram-Positive Bacterial Infections --- Physiological Phenomena --- Bacterial Infections --- Bacterial Infections and Mycoses --- Communicable Diseases --- Health & Biological Sciences --- Prevention --- Resistance to drugs --- MDR-TB (Multidrug-resistant tuberculosis) --- MDR tuberculosis --- Polydrug-resistant tuberculosis --- Consumption (Disease) --- Lungs --- Phthisis --- Pulmonary tuberculosis --- TB (Disease) --- Pharmacology --- Drug resistance in microorganisms --- Multidrug resistance --- Chest --- Mycobacterial diseases --- Mycobacterium tuberculosis